C. Patel

STEAP1 as a predictive biomarker for antibody-drug conjugate (ADC) activity in metastatic castration resistant prostate cancer (mCRPC).

M. Morris, H. Scher, J. Carrasquillo, 2015 .

Clinical Validity of Detecting Circulating Tumor Cells by AdnaTest Assay Compared With Direct Detection of Tumor mRNA in Stabilized Whole Blood, as a Biomarker Predicting Overall Survival for Metastatic Castration-Resistant Prostate Cancer Patients

H. Scher, M. Fleisher, D. Danila, 2016, Cancer journal.

Analysis of AR-FL and AR-V1 in Whole Blood of Patients with Castration Resistant Prostate Cancer as a Tool for Predicting Response to Abiraterone Acetate.

T. Visakorpi, H. Lilja, D. Danila, 2019, The Journal of urology.

Renal cell carcinoma: a reappraisal.

P. Ellsworth, C. Patel, Asma Ahmed, 2012, Urologic nursing.

MicroRNA Expression Profiles in Upper Tract Urothelial Carcinoma Differentiate Tumor Grade, Stage, and Survival: Implications for Clinical Decision-Making.

D. Canes, J. Raman, E. Burks, 2019, Urology.

A pilot study comparing circulation tumor cells (CTC) detection by AdnaTest prostate assay to CellSearch in patients (pts) with castration resistant prostate cancer (CRPC).

H. Scher, M. Fleisher, D. Danila, 2013 .